R788

· Rigel Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for R788, covering 2023-12-11 to 2023-12-11. Get the full timeline:

Most recent: Clinical Trial Update: Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) [Phase 3]